T/FIF Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (776)	4/10/1999 9:41:00 PM
From: scaram(o)uche	Read Replies (1) of 1073

Heated debate at the Biotech Rumor Mill over ISIP and antisense. Please conduct a search there. The thread has been ongoing for what seems forever, and the [well-informed] individual who is attacking the company seems to have a personal vendetta. I haven't owned it since '95, and only owned it for a bit then. ICAM-1 is an interesting project, but.... I don't know of anyone pursuing MAb anti-ICAM-1. Maybe I just missed it. But, it's sort of strange that the CEO of LKST used to lead the ICAM/inflammation project at ISIP, and that LKST isn't pursuing anti-ICAM. Why'd he leave in the first place? I went to an ISIP open house in '95 (or '96?) where they were representing an anti-HIV agent as a potential product when they knew damn well that animal testing at SyStemix made it look ineffective. Left a bad taste. Also, check out the history of scientific fraud with their molecule by a partner.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next